• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 3. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 4. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 5. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Heteroaromatic compounds Heteroaromatic compounds
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Heteroaromatic compounds

Research Briefing on 2-Thiophen-3-yl-acetamidine Hydrochloride (CAS: 860815-14-1): Recent Advances and Applications

2-Thiophen-3-yl-acetamidine Hydrochloride (CAS: 860815-14-1) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. This amidine derivative, characterized by its thiophene moiety, has recently garnered attention due to its potential applications in drug discovery and development. The compound's unique structural features make it a promising candidate for modulating biological targets, particularly in the context of enzyme inhibition and receptor binding.

Recent studies have explored the synthesis and pharmacological properties of 2-Thiophen-3-yl-acetamidine Hydrochloride. A 2023 publication in the Journal of Medicinal Chemistry highlighted its role as a potent inhibitor of serine proteases, a class of enzymes implicated in various pathological conditions, including inflammatory diseases and cancer. The study demonstrated that the compound exhibits high selectivity and affinity for specific protease targets, suggesting its potential as a lead compound for therapeutic development.

In addition to its protease inhibitory activity, 2-Thiophen-3-yl-acetamidine Hydrochloride has been investigated for its interactions with G protein-coupled receptors (GPCRs). A preprint article from BioRxiv (2024) reported that the compound modulates the activity of certain GPCRs involved in neurotransmission, opening new avenues for research in neurological disorders. The study employed a combination of computational docking and in vitro assays to elucidate the binding mechanisms and functional outcomes of these interactions.

The synthetic accessibility of 2-Thiophen-3-yl-acetamidine Hydrochloride has also been a focus of recent research. A 2023 paper in Organic & Biomolecular Chemistry described an optimized synthetic route that improves yield and purity while reducing the use of hazardous reagents. This advancement is critical for scaling up production and facilitating further pharmacological evaluations.

Despite these promising findings, challenges remain in the development of 2-Thiophen-3-yl-acetamidine Hydrochloride as a therapeutic agent. Issues such as metabolic stability, bioavailability, and potential off-target effects need to be addressed in future studies. However, the compound's versatility and demonstrated biological activity underscore its value as a tool for chemical biology and a potential candidate for drug development.

In conclusion, 2-Thiophen-3-yl-acetamidine Hydrochloride (CAS: 860815-14-1) represents a compelling area of research in the chemical biology and pharmaceutical fields. Its diverse biological activities and synthetic tractability make it a valuable compound for further investigation. Continued research efforts will likely uncover additional applications and refine its therapeutic potential, contributing to the advancement of targeted therapies in medicine.

• 861198-53-0(2-(thiophen-3-yl)ethanimidamide)
• 34843-84-0(2-(thiophen-3-yl)ethan-1-amine hydrochloride)
• 144757-40-4(3-(thiophen-3-yl)propanimidamide)
• 2228177-82-8(4-(thiophen-3-yl)butanimidamide)
• 2229559-96-8(2-(4-methylthiophen-3-yl)ethanimidamide)
• 155601-61-9(N-HYDROXY-2-THIOPHEN-3-YL-ACETAMIDINE)
• 59311-67-0(2-(thiophen-3-yl)ethan-1-amine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)